Drug intelligence / Profile preview

Spizef

Development stage
Unknown
Lead developer
Orchid Pharma
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Spizef is a brand of cefuroxime, a second-generation cephalosporin antibiotic developed and manufactured by Orchid Chemicals and Pharma. It is utilized for the treatment of various bacterial infections, including those of the respiratory tract, urinary tract, skin, and soft tissues, as well as for surgical prophylaxis. The drug functions by binding to bacterial penicillin-binding proteins (PBPs), thereby inhibiting the transpeptidation step of peptidoglycan synthesis. This disruption of cell wall assembly leads to bacterial cell lysis and death. Spizef is available in two distinct forms: cefuroxime axetil for oral administration (tablets) and cefuroxime sodium for parenteral administration (intravenous or intramuscular injection).

Brand names
Spizef
Other names
cefuroxime axetilcefuroxime sodiumcefuroxime
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Spizef.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spizef.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call